Home/Pipeline/ShearWave Elastography Clinical Expansion

ShearWave Elastography Clinical Expansion

Breast Lesion Characterization

CommercialActive

Key Facts

Indication
Breast Lesion Characterization
Phase
Commercial
Status
Active
Company

About SuperSonic Imagine

SuperSonic Imagine is a pioneer in ultrasound imaging, known for its proprietary ShearWave Elastography technology, which provides quantitative tissue stiffness measurements in real-time. The company targets the global diagnostic imaging market with systems used in radiology, obstetrics/gynecology, and other clinical specialties. As a historically public company that faced financial challenges, it was acquired by Hologic, Inc. in 2021, integrating its technology into a larger portfolio. Its core value proposition lies in enhancing diagnostic capabilities beyond conventional anatomical ultrasound.

View full company profile

About SuperSonic Imagine

SuperSonic Imagine is a pioneer in ultrasound imaging, known for its proprietary ShearWave Elastography technology, which provides quantitative tissue stiffness measurements in real-time. The company targets the global diagnostic imaging market with systems used in radiology, obstetrics/gynecology, and other clinical specialties. As a historically public company that faced financial challenges, it was acquired by Hologic, Inc. in 2021, integrating its technology into a larger portfolio. Its core value proposition lies in enhancing diagnostic capabilities beyond conventional anatomical ultrasound.

View full company profile

About SuperSonic Imagine

SuperSonic Imagine is a pioneer in ultrasound imaging, known for its proprietary ShearWave Elastography technology, which provides quantitative tissue stiffness measurements in real-time. The company targets the global diagnostic imaging market with systems used in radiology, obstetrics/gynecology, and other clinical specialties. As a historically public company that faced financial challenges, it was acquired by Hologic, Inc. in 2021, integrating its technology into a larger portfolio. Its core value proposition lies in enhancing diagnostic capabilities beyond conventional anatomical ultrasound.

View full company profile